Stay updated on Combining GEN0101 and Pembrolizumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Combining GEN0101 and Pembrolizumab in Melanoma Clinical Trial page.

Latest updates to the Combining GEN0101 and Pembrolizumab in Melanoma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page revision/version label was updated from v3.5.2 to v3.5.3, indicating a minor update to the ClinicalTrials.gov page release rather than changes to the underlying study information.SummaryDifference0.1%

- Check18 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0. This is a minor maintenance/versioning update that does not affect the study details.SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check47 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check61 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check84 days agoChange DetectedRevision: v3.4.2 has been added and the government funding status notice, along with the Revision: v3.4.1 label, was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check91 days agoChange DetectedA government funding/status notice was added and the page template updated to Revision: v3.4.1, replacing the previous v3.4.0.SummaryDifference0.4%

Stay in the know with updates to Combining GEN0101 and Pembrolizumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Combining GEN0101 and Pembrolizumab in Melanoma Clinical Trial page.